Perioperative medicine & outcomes

Association between hydroxyethyl starch 130/0.4 administration during noncardiac surgery and postoperative acute kidney injury: A propensity score-matched analysis of a large cohort in China

J Clin AnesthPublished Retrospective cohort study

Main findingResult — go to the resultOdds ratio 0.90 CI 0.74–1.08

Authors' conclusion

Hydroxyethyl starch 130/0.4 use was not significantly associated with a greater incidence of postoperative acute kidney injury compared to receiving crystalloid solutions only.

Study context

Population
Chinese adults undergoing noncardiac surgery, one tertiary care hospital, 2013–2022
Participants
51,926 adults · 11,725 matched pairs
Exposure
Hydroxyethyl starch vs Crystalloid
Outcome
Incidence of AKI
Methodological detailspropensity-score matched, single-centre
  • Propensity-score matched
  • Single-centre

Main finding

As reported in the abstract

Odds ratio

0.90

CI 0.74–1.08

P = 0.25

By group

Hydroxyethyl starch vs Crystalloid
OR 0.90 (CI 0.74–1.08); P = 0.25

Observational data: associations, not effects.

Further findings

OutcomeOR (CI)P value
AKI stagePropensity-matched cohort0.90 (0.75–1.08)P = 0.26

Outcomes in patients at high risk of renal injury (subgroup)

Hydroxyethyl starch use not associated with worse outcomes

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Association between hydroxyethyl starch 130/0.4 administration during noncardiac surgery and postoperative acute kidney injury: A propensity score-matched analysis of a large cohort in China. J Clin Anesth. Published 8 May 2024. doi:10.1016/j.jclinane.2024.111493

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.